Claudio Anasetti

Active 1986–2024

162
Papers
32,021
Citations
103
h-index
161
i10-index

Citations

Citations per year for Claudio Anasetti1948: 1 citations1976: 1 citations1983: 1 citations1986: 1 citations1987: 3 citations1988: 2 citations1989: 6 citations1990: 19 citations1991: 18 citations1992: 24 citations1993: 65 citations1994: 102 citations1995: 98 citations1996: 99 citations1997: 131 citations1998: 147 citations1999: 154 citations2000: 212 citations2001: 280 citations2002: 306 citations2003: 377 citations2004: 315 citations2005: 274 citations2006: 250 citations2007: 254 citations2008: 220 citations2009: 263 citations2010: 259 citations2011: 182 citations2012: 205 citations2013: 190 citations2014: 247 citations2015: 179 citations2016: 163 citations2017: 130 citations2018: 117 citations2019: 545 citations2020: 469 citations2021: 487 citations2022: 348 citations2023: 293 citations2024: 436 citations2025: 167 citations2026: 3 citations1949–1975: no citations, so these years are not shown1977–1982: no citations, so these years are not shown1984–1985: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,949 citing papers, 32.7% of this breakdownGermany: 684 citing papers, 7.6% of this breakdownUnited Kingdom: 549 citing papers, 6.1% of this breakdownFrance: 524 citing papers, 5.8% of this breakdownItaly: 488 citing papers, 5.4% of this breakdownCanada: 329 citing papers, 3.6% of this breakdownNetherlands: 323 citing papers, 3.6% of this breakdownChina: 312 citing papers, 3.4% of this breakdownSpain: 306 citing papers, 3.4% of this breakdownJapan: 295 citing papers, 3.3% of this breakdownSweden: 213 citing papers, 2.4% of this breakdownSwitzerland: 191 citing papers, 2.1% of this breakdown
0%32.7%Other 20.6%

Fields

  • Medicine75.4%
  • Immunology and Microbiology17.8%
  • Biochemistry, Genetics and Molecular Biology4.9%
  • Pharmacology, Toxicology and Pharmaceutics0.4%
  • Neuroscience0.3%
  • Physics and Astronomy0.3%
  • Other0.9%

Topics

  • Hematopoietic Stem Cell Transplantation17.4%
  • T-cell and B-cell Immunology8.3%
  • Immune Cell Function and Interaction8%
  • Acute Myeloid Leukemia Research6.1%
  • Acute Lymphoblastic Leukemia research4.3%
  • Immunotherapy and Immune Responses3.4%
  • Other52.5%

Coauthors

All papers

Open in search
  1. Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Blood 2021 cited by 292

  2. National Marrow Donor Program–Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 cited by 213

  3. The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy

    Authors: , , , , , , , , , , , , , , , , , , , , - Blood 2015 cited by 353

  4. Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2017 cited by 376

  5. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation

    Authors: , , , , , , , , , , , , , , , , , - Blood 2007 cited by 1,240

  6. Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2012 cited by 905

  7. Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-Sponsored Prospective Clinical Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Transplantation and Cellular Therapy 2022 cited by 53

  8. Human Cytomegalovirus (CMV)-Induced Memory-like NKG2C+ NK Cells Are Transplantable and Expand In Vivo in Response to Recipient CMV Antigen

    Authors: , , , , , , , , - The Journal of Immunology 2012 cited by 358

  9. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age

    Authors: , , , , , , , , , , , , - Blood 2001 cited by 702

  10. Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2014 cited by 280

  11. Increased Infections and Delayed CD4+ T Cell but Faster B Cell Immune Reconstitution after Post-Transplantation Cyclophosphamide Compared to Conventional GVHD Prophylaxis in Allogeneic Transplantation

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Transplantation and Cellular Therapy 2021 cited by 49

  12. Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors.

    Authors: , , , , , , , , , , , , , , - 2000 cited by 591

  13. Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell–Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 cited by 327

  14. Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors

    Authors: , , , , , , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2015 cited by 169

  15. Chronic graft-versus-host disease and other late complications of bone marrow transplantation.

    Authors: , , , , , , , , , - 1991 cited by 802

  16. Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly

    Authors: , , , , - Blood 2011 cited by 140

  17. Randomized multicenter trial of sirolimus vs prednisone as initial therapy for standard-risk acute GVHD: the BMT CTN 1501 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , - Blood 2019 cited by 84

  18. Human CD83-targeted chimeric antigen receptor T cells prevent and treat graft-versus-host disease

    Authors: , , , , , , , , , , , , , , - Journal of Clinical Investigation 2020 cited by 60

  19. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.

    Authors: , , , , , , - The Journal of Experimental Medicine 1992 cited by 583

  20. Tumor Microenvironment Composition and Severe Cytokine Release Syndrome (CRS) Influence Toxicity in Patients with Large B-Cell Lymphoma Treated with Axicabtagene Ciloleucel

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2020 cited by 83

  21. The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure

    Authors: , , , , , , , - Blood 2010 cited by 273

  22. Quality of life after allogeneic hematopoietic cell transplantation

    Authors: , , - Blood 2009 cited by 315

  23. Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Navneet S. Majhail, Ann E. Woolfrey, Ian Nivison‐Smith, Mark Hertzberg, Miguel Ángel Díaz, Ann A. Jakubowski, Celalettin Üstün, Agnes S. M. Yong, César O. Freytes, Zachariah DeFilipp, Yoshi Inamoto, Jean‐Yves Cahn, Bipin N. Savani, Jean A. Yared, Ashish Bajel, Ulrike Bacher, Geoffrey L. Uy, David A. Rizzieri, Matthew J. Wieduwilt, Kirk R. Schultz, Michael R. Grunwald, Rammurti T. Kamble, Muna Qayed, Jonathan E. Brammer, Karen K. Ballen, Nandita Khera, Harry C. Schouten, Marc Bierings, Christopher G. Kanakry, William A. Wood, Ayman Saad, Lynn Savoie, Betty K. Hamilton, Mahmoud Aljurf, Ravi Vij, Attaphol Pawarode, Richard F. Olsson, Baldeep Wirk, Amer Beitinjaneh, Sachiko Seo, Jan Černý, Görgün Akpek, Maxim Norkin, Taiga Nishihori, Aleksandr Lazaryan, Mitchell Sabloff - Biology of Blood and Marrow Transplantation 2017 cited by 97

  24. Comparison of Patient-Reported Outcomes in 5-Year Survivors Who Received Bone Marrow vs Peripheral Blood Unrelated Donor Transplantation

    Authors: , , , , , , , , , , , , - JAMA Oncology 2016 cited by 130